• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Poland·Financial Services·MBK.WA
Share

mBank S.A. Stocks

PLN 1418.5Last Updated 26.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

PLN 15.08B

PLN 1418.5
Key Takeaways

Risk factor

Limited default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

mBank S.A. is a prominent financial institution delivering a comprehensive array of banking and financial services across Poland, the Czech Republic, Slovakia, and international markets. Its extensive offerings encompass a variety of account types, such as personal, savings, currency, investment, and business accounts, alongside diverse deposit options. The bank provides bill and credit cards, and a range of loan products including cash, vehicle, revolving, corporate, and mortgage financing. Additionally, clients can access pension schemes, insurance solutions, and stock exchange products, supported by modern transaction and mobile banking platforms. In terms of wealth management, mBank offers sophisticated services like asset management, investment advisory, access to various investment funds and tailored fund portfolios, and succession planning. The institution also facilitates foreign exchange transactions, currency deposits, and forex forward contracts. Its debt securities portfolio includes government, non-government, and Eurobonds. Further specialized services comprise factoring, leasing, investment credit, invoicing and accounting assistance, brokerage, and currency handling. Operating through 322 branches, mBank S.A. was founded in 1986. Originally known as BRE Bank S.A., the company officially adopted the mBank S.A. name in November 2013. Headquartered in Warsaw, Poland, mBank S.A. functions as a subsidiary of Commerzbank AG.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, underpriced on P/RIBP.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of MBK.WA is 1236 and suggests 12.9% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.10.2026 09:01

Insiders, a competitor, a philanthropist, and an activist: Who owns shares in Anthropic?

28.10.2026 08:30

Wall Street has identified Broadcom as a major beneficiary of Anthropic's IPO. Who else stands to gain?

28.10.2026 08:01

"Too Big a Chicken": McDonald's Partners Deem the New Menu a Failure

28.10.2026 07:01

Healthcare stocks have become a bet against AI. Should you buy them?

28.10.2026 03:18

"The conditions for a rebound are ripe": Stocks rise for a second day ahead of big tech earnings reports

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026